Omicron India
- All
- News
- Videos
-
Delhi Reports First Case Of JN.1Covid Sub-Variant: Signs And Symptoms To Watch Out For
The World Health Organisation has classified the JN.1 variant as a 'variant of interest.' It is a descendant of the BA.2.86 variant (an Omicron sub-variant).
-
"Hospitalisations Will Go Up As Covid Burden Increases": Soumya Swaminathan
Over a year-and-a-half after India witnessed the Omicron wave, two eminent health experts have sounded a warning over the increasing Covid-19 cases in India in the wake of the JN.1 sub-variant of Omicron being detected in the country.
-
Gennova mRNA Covid Booster Vaccine Gets Emergency Use Authorisation
Pune-based Gennova Biopharmaceuticals Ltd on Tuesday said its mRNA COVID-19 booster vaccine against the Omicron variant, GEMCOVAC-OM, has received emergency use authorisation from the Drugs Controller General of India.
-
XBB.1.16 Variant Most Dominant Strain Of Covid In India: Health Body
More than 1,300 samples of Omicron sub-variant XBB2.3 have been detected in India, while XBB.1.16 has become the dominant strain in the country, according to INSACOG data.
-
India's Daily Covid Count Crosses 12,000, Sharp Rise Since Yesterday
India recorded 12,591 news COVID-19 cases in the last 24 hours, 20 per cent higher than yesterday. Medical experts have said Omicron sub-variant XBB.1.16 could be driving the surge in cases.
-
Covid-19 In India: This Is The New Symptom Of The XBB.1.16 Variant; Here Are Other Symptoms
India has logged 10,158 fresh Covid-19 cases over the past 24 hours. It is believed that the Omicron subvariant, XBB.1.16 is driving the latest surge in the country.
-
Arcturus, New Covid Variant, Has New Symptom "Not Seen In Earlier Waves"
The omicron subvariant XBB.1.16 is the main cause of the surge. According to the WHO, the subvariant and its spread in India are being monitored.
-
234 Cases Of Mutated Omicron Sub-Variant (XBB1.16.1) Found In India
Amid a spurt in fresh Covid infections, 234 cases of XBB1.16.1 mutated sub-variant have been found in the country, according to INSACOG data.
-
India Records 5,880 Covid Cases In 24 Hours: Do Not Ignore These Symptoms Of The XBB.1.16 Variant
The new Covid-19 variant, XBB.1.16 is responsible for the surge in cases in India. According to the Health Ministry data, India has reported a total of 5,880 covid cases in the last 24 hours.
-
Covid Variant XBB1.16 Driving Spike In Cases, See Symptoms And Precautions
Symptoms of this variant include fever that gradually climbs and lasts for 1-2 days, sore throat, bodily soreness, headaches and abdominal discomfort.
-
XBB.1.16, New Covid-19 Variant: What We Know So Far
Fever, sore throat, body pain, headaches and abdominal discomfort are some of the symptoms of the XBB.1.16 variant.
-
Omicron's Sub-Variant Hasn't Increased Hospitalisations: Health Minister
In the wake of rising COVID cases in India, Union Health Minister Mansukh Mandaviya on Monday said that Omicron's sub-variant which is circulating in the country has not led to the increase in hospitalisations and there is no need to worry.
-
No Increase In Death Rates Amid Rising Covid Cases: Health Ministry
The Union Health Ministry said on Thursday that the XBB.1.16 subvariant of Omicron might be the dominant virus strain in the country but there has been no reported increase in the rate of hospitalisation or death so far.
-
Omicron, Its Sub-Lineages Dominant Covid Variants In India: Centre
Omicron and its sub-lineages continue to be the dominant coronavirus variants in India, Minister of State for Health Bharati Pravin Pawar told the Lok Sabha on Friday.
-
Covovax To Get Approval As Covid Booster In 10-15 Days: Adar Poonawalla
Serum Institute of India chief executive officer Adar Poonawalla on Sunday said its Covovax vaccine will get approval as a booster in the next 10 to 15 days, adding it works well against the Omicron variant of coronavirus.
-
Delhi Reports First Case Of JN.1Covid Sub-Variant: Signs And Symptoms To Watch Out For
The World Health Organisation has classified the JN.1 variant as a 'variant of interest.' It is a descendant of the BA.2.86 variant (an Omicron sub-variant).
-
"Hospitalisations Will Go Up As Covid Burden Increases": Soumya Swaminathan
Over a year-and-a-half after India witnessed the Omicron wave, two eminent health experts have sounded a warning over the increasing Covid-19 cases in India in the wake of the JN.1 sub-variant of Omicron being detected in the country.
-
Gennova mRNA Covid Booster Vaccine Gets Emergency Use Authorisation
Pune-based Gennova Biopharmaceuticals Ltd on Tuesday said its mRNA COVID-19 booster vaccine against the Omicron variant, GEMCOVAC-OM, has received emergency use authorisation from the Drugs Controller General of India.
-
XBB.1.16 Variant Most Dominant Strain Of Covid In India: Health Body
More than 1,300 samples of Omicron sub-variant XBB2.3 have been detected in India, while XBB.1.16 has become the dominant strain in the country, according to INSACOG data.
-
India's Daily Covid Count Crosses 12,000, Sharp Rise Since Yesterday
India recorded 12,591 news COVID-19 cases in the last 24 hours, 20 per cent higher than yesterday. Medical experts have said Omicron sub-variant XBB.1.16 could be driving the surge in cases.
-
Covid-19 In India: This Is The New Symptom Of The XBB.1.16 Variant; Here Are Other Symptoms
India has logged 10,158 fresh Covid-19 cases over the past 24 hours. It is believed that the Omicron subvariant, XBB.1.16 is driving the latest surge in the country.
-
Arcturus, New Covid Variant, Has New Symptom "Not Seen In Earlier Waves"
The omicron subvariant XBB.1.16 is the main cause of the surge. According to the WHO, the subvariant and its spread in India are being monitored.
-
234 Cases Of Mutated Omicron Sub-Variant (XBB1.16.1) Found In India
Amid a spurt in fresh Covid infections, 234 cases of XBB1.16.1 mutated sub-variant have been found in the country, according to INSACOG data.
-
India Records 5,880 Covid Cases In 24 Hours: Do Not Ignore These Symptoms Of The XBB.1.16 Variant
The new Covid-19 variant, XBB.1.16 is responsible for the surge in cases in India. According to the Health Ministry data, India has reported a total of 5,880 covid cases in the last 24 hours.
-
Covid Variant XBB1.16 Driving Spike In Cases, See Symptoms And Precautions
Symptoms of this variant include fever that gradually climbs and lasts for 1-2 days, sore throat, bodily soreness, headaches and abdominal discomfort.
-
XBB.1.16, New Covid-19 Variant: What We Know So Far
Fever, sore throat, body pain, headaches and abdominal discomfort are some of the symptoms of the XBB.1.16 variant.
-
Omicron's Sub-Variant Hasn't Increased Hospitalisations: Health Minister
In the wake of rising COVID cases in India, Union Health Minister Mansukh Mandaviya on Monday said that Omicron's sub-variant which is circulating in the country has not led to the increase in hospitalisations and there is no need to worry.
-
No Increase In Death Rates Amid Rising Covid Cases: Health Ministry
The Union Health Ministry said on Thursday that the XBB.1.16 subvariant of Omicron might be the dominant virus strain in the country but there has been no reported increase in the rate of hospitalisation or death so far.
-
Omicron, Its Sub-Lineages Dominant Covid Variants In India: Centre
Omicron and its sub-lineages continue to be the dominant coronavirus variants in India, Minister of State for Health Bharati Pravin Pawar told the Lok Sabha on Friday.
-
Covovax To Get Approval As Covid Booster In 10-15 Days: Adar Poonawalla
Serum Institute of India chief executive officer Adar Poonawalla on Sunday said its Covovax vaccine will get approval as a booster in the next 10 to 15 days, adding it works well against the Omicron variant of coronavirus.
